90
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Uranyl and transition metal chelates of tenoxicam. Crystal structures of trans,trans-[Co(II)(Hten)2(dmso)2], trans,trans-[Zn(II)(Hten)2(dmso)2] and cis,cis-[UO2(VI)(Hten)2(H2O)] · 2C2H5OH

&
Pages 2246-2265 | Received 29 Mar 2007, Accepted 21 Sep 2007, Published online: 01 Jul 2008
 

Abstract

The synthesis and characterization of ternary Fe(III)- (1), Co(II)- (2), Ni(II)- (3), Cu(II)- (4), Zn(II)- (5) and UO2(VI)- (6) chelates with the potent anti-inflammatory drug tenoxicam (H2ten) and (dl-alanine, Hala) are reported. All complexes are octahedral except Cu(II) and Zn(II) chelates, which are tetrahedral, and U-atoms in the uranyl chelates have a pentagonal-bipyramidal coordination sphere. The ternary Co(II) and Zn(II) complexes dissociate in dmso where orange and yellow crystals of trans,trans-[Co(II)(Hten)2(dmso)2] (8) and trans,trans-[Zn(II)(Hten)2(dmso)2] (9), respectively, were obtained. Crystallization of the binary uranyl chelate (7) from ethanol afforded the ethanol solvate cis,cis-[UO2(VI)(Hten)2(H2O)] · 2C2H5OH (7a). trans,trans-[Co(II)(Hten)2(dmso)2] (8) and trans,trans-[Zn(II)(Hten)2(dmso)2] (9) crystallize in the monoclinic space group P21/n while 7a crystallizes in the triclinic space group . The kinetics of the thermal decompositions for 1, 3, 4, 6 and 7 were studied and the thermodynamic parameters E*, ΔH*, ΔS* and ΔG* evaluated.

Acknowledgements

The authors are thankful to J. Wagler for his help and useful discussion. N.E.A. El-Gamel is grateful to the Alexander von Humboldt Foundation, Bonn, Germany for financing a 9 month stay at the Inorganic Institute, TU Bergakademie Freiberg, Germany.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.